Tag Archives: Dementia Research

Earlier Diagnosis Research: the Deep and Frequent Phenotyping Study (BBC News / GtR)

Posted on June 28, 2017 by Dementia and Elderly Care News

Summary The Deep and Frequent Phenotyping Study aims to discover new ways of diagnosing dementia, ideally decades before the symptoms become apparent in order to give future drug treatments the best chance of working. The Deep and Frequent Phenotyping Study … Continue reading →

Posted in Alzheimer's Society, BBC News, Commissioning, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Mental Health, Models of Dementia Care, National, NIHR, Quick Insights, UK, Universal Interest | Tagged Ageing Population, Alterations in Movement and Walking (“Gait”) Assessments, Alzheimer's Disease: Early Detection by Brain Scan, Alzheimer’s Disease Biomarkers, Amnestic Mild Cognitive Impairment (a-MCI), Amnestic Mild Cognitive Impairment (aMCI), Applications of Big Data, BBC Radio, BBC Radio 4, BBC's World At One Programme, Big Data Analytics, Big Data Funding and Research, Biomarker Assessments in Alzheimer’s Disease, Biomarker Assessments in Alzheimer’s Disease Clinical Trials, Biomarker Assessments in Clinical Trials, Biomarker Development, Biomarkers, Biomarkers Predicting Cognitive Decline and Alzheimer's Disease, Biomarkers Research Programmes, Blood and Urine Biomarkers, Blood-Based Biomarkers, Blood-Based Biomarkers of Pre-Symptomatic Alzheimer’s Disease, Brain Scans, Cambridge Neuropsychological Test Automated Battery (CANTAB), Cerebrospinal Fluid (CSF) Biomarkers, Clinical Assessments, Cognitive Assessments / Screening Tools, Conversion to Dementia From Prodromal Disease, CSF Biomarkers, Deep and Frequent Phenotyping Study, Deep and Frequent Phenotyping Study (DFP), Deep and Frequent Phenotyping; Combinatorial Biomarkers of Dementia, Dementia Research, Dementia Research Funding, Dementias Platform UK, Dementias Platform UK (DPUK), Dementias Platform UK: MRC, DFP Study Team, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, DPUK: Dementias Platform UK, Drug Trials Failure Rate, Early Detection of Alzheimer’s Disease, Early Detection of Preclinical Disease, EEG: Electroencephalography, Effectiveness of Early Detection and Treatment, Electroencephalogram (EEG) Brain Scans, Electroencephalography (EEG), Gait and Cognition, Gait Changes, Gateway to Research (GtR), Global Dementia Research, Global Leadership, Hypothetical Prodromes of Dementia, Imanova, Imperial College London, Join Dementia Research, Join Dementia Research: Clinical Trials Matchmaker Service, Join Dementia Research: Recruitment Onto Dementia Studies, Kings College London, Magnetic Resonance Imaging (MRI) Scan, Magnetoencephalography (MEG), Medical Research Council (MRC), Medical Research Council (UK), National Institute of Health Research (NIHR), Neurobiology of Aging (Journal), Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurodegenerative Research, Newcastle University, Non-Invasive Biomarkers, Ocular Manifestations in Neurodegenerative Diseases, Open Data and Big Data, Ophthalmological Assessments, Participation in Research, Participation in Research Studies, Partnership and Collaboration, Patient and Public Participation, PharmaCog Consortium, Positron Emission Tomography (PET), Pre-Clinical Genotype-Phenotype Predictors of Alzheimer's Disease, Prodromal Alzheimer's Disease, Professor Clare Mackay: Imaging Neuroscience at the University of Oxford, Professor Lynn Rochester: Clinical Ageing Research Unit at Newcastle University, Professor Simon Lovestone: Lead Researcher and Professor of Translational Neuroscience at University of Oxford, Protein-Based Biomarkers in Blood May Deliver Accurate Diagnoses, Proteomic Analysis, Proteomics, Public Participation in Research, Publicly-Funded UK Big Data Research, Research and Development, Research and Innovation, Research Commitment, Research Culture, Research Funding, Retina as Early Biomarker of Neurodegeneration, Retinal Biomarkers, Retinal Changes as Surrogate Biomarker for Alzheimer's Disease, Retinal Ganglion Cells (RGCs), Retinal Manifestations of Alzheimer's Disease, Screening Tools for Amnestic Mild Cognitive Impairment (a-MCI), Surrogate Biomarkers of Neurodegeneration, Translational Research, University College London, University of Cambridge, University of Edinburgh, University of Manchester, University of Oxford, Volunteers, Walking Pattern (Gait), Wearable Devices, Wearables (Technology) | Leave a comment

David Cameron on Need for Increasing Dementia Research Funding (BBC News)

Posted on January 26, 2017 by Dementia and Elderly Care News

Summary David Cameron, the former Prime Minister, has taken-up the role of President of Alzheimer’s Research UK (in addition to working for the National Citizen Service). He has proposed / re-stated the importance of greater levels of funding for dementia … Continue reading →

Posted in Alzheimer’s Research UK, BBC News, Commissioning, In the News, Management of Condition, Mental Health, National, Non-Pharmacological Treatments, Person-Centred Care, Quick Insights, UK, Universal Interest | Tagged Alzheimer's Research UK, Alzheimer’s Research UK (ARUK), ARUK: Alzheimer’s Research UK, BBC Health News, BBC Politics News, Challenge on Dementia (David Cameron), Challenge on Dementia 2020, David Cameron, David Cameron: Former Prime Minister, David Cameron: President of Alzheimer's Research UK, Defeat Dementia Campaign, Defeat Dementia Campaign (Alzheimer’s Research UK), Dementia Awareness, Dementia Awareness Raising, Dementia Research, Dementia Research Funding, Dementia Risk Prevention, Dementia Risk Reduction and Prevention, Dementia-Friendly Communities, Dementia-Friendly Environments, Investment in Dementia Prevention, National Citizen Service, National Citizen Service in England and Northern Ireland, Prevention Agenda, Prime Minister's Challenge on Dementia, Prime Minister’s Challenge On Dementia 2020, The Rt Hon David Cameron: President of Alzheimer’s Research UK | Leave a comment

NICE Participation in European ROADMAP Project: Faster Access to Alzheimer’s Disease Drugs? (NICE)

Posted on January 12, 2017 by Dementia and Elderly Care News

Summary NICE is participating in the ROADMAP initiative, which is working on a sustainable platform for “real world” evidence generation concerning Alzheimer’s Disease and (hopefully) faster development of disease-modifying drugs. “The IMI (Innovative Medicines Initiative) is Europe’s largest public-private partnership, … Continue reading →

Posted in Commissioning, For Researchers (mostly), In the News, International, National, Quick Insights, UK, Universal Interest | Tagged Academia-Industry Partnerships, Big Data, Big Data for Better Outcomes Programme (IMI), Big Data Funding and Research, Collaborative Projects, Cross-Sector Partnerships, Data Sharing, Dementia Research, Disease Modification, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Treatments for Dementia, Dr Matthew Norton: Alzheimer's Research UK, Electronic Health Records (EHRs), European ROADMAP Project, Global Leadership, Global Outlook, IMI (Innovative Medicines Initiative), IMI’s Big Data for Better Outcomes Programme, Innovative Medicines Initiative (IMI), International Collaborations, International Programmes, Leveraging Big Data, National Institute for Health and Care Excellence (NICE), Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, NICE’s Science Policy and Research Programme, Pan-European Collaborations, Partnership, Partnership and Collaboration, Partnership Working, Prof Carole Longson: National Institute for Health and Care Excellence (NICE), Professor Carole Longson: Director of Centre for Health Technology Evaluation at NICE, Professor John Gallacher: University of Oxford, Promisary Science, Publicly-Funded UK Big Data Research, Research and Innovation, Resource and Incentives, ROADMAP Initiative | Leave a comment

Future Director of the UK Dementia Research Institute (MRC / Guardian / JAMA Neurology)

Posted on December 14, 2016 by Dementia and Elderly Care News

Summary Professor Bart De Strooper has been appointed as the Director of the UK Dementia Research Institute (UK DRI). Prof. De Strooper currently leads the Laboratory for the Research of Neurodegenerative Diseases at the University of Leuven and is scientific … Continue reading →

Posted in For Researchers (mostly), In the News, International, Models of Dementia Care, National, Quick Insights, UK, Universal Interest | Tagged Ageing Population, Belgium, Biomarker Development, Biomarkers, Biomarkers Research Programmes, Brain Imaging, Dementia and Alzheimer's Disease: Leading Cause of Death in 2015, Dementia Challenge 2020, Dementia Research, Dementia Research Careers, Dementia Research Institute (DRI), Dementia Research: Roadmap for the Next Decade, Department of Neuroscience: Mayo Clinic Florida, Diagnostic Imaging, Diagnostics, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, Drug Discovery Programmes, Environmental Risk Factors, Epidemiology, G8 Dementia Summit Declaration, Genetics, Global Action Against Dementia, Global Context, Global Leadership, Guardian, Guardian (Newspaper), International Dementia Research, International Dementia Research Inventories, JAMA Neurology, Jo Johnson: Universities and Science Minister, Johns Hopkins University, Laboratory for the Research of Neurodegenerative Diseases: University of Leuven, Laboratory of Neurogenetics: National Institute on Aging, Lifestyle Risk Factors, Mayo Clinic Florida, Medical Research Council (MRC), Medical Research Council (UK), Michael Arthur: UCL President and Provost Professor, MRC: Medical Research Council, National Institutes of Health (NIH), National Institutes of Health (US), National Institutes of Health / National Institutes on Aging, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurodegenerative Research, Neuroimaging of Dementia, Neurology, Neuromuscular Diseases Research Section: National Institute on Aging, Neuroscience, Overlapping Risk Factors, Potential Drug Targets, Preclinical Biomarkers and Dementia, Professor Bart De Strooper: Director of the UK Dementia Research Institute (UK DRI), Recruitment of Research Leaders / Rising Stars, Research and Development, Research and Innovation, Research Commitment, Sir John Savill: Chief Executive of the Medical Research Council, UCL DRI Hub, UK Dementia Research Institute, UK Dementia Research Institute (UK DRI), United States, University College London (UCL), University of Leuven, US National Institutes of Health, US National Institutes of Health (NIH), USA, VIB (Belgium), VIB-K.U.Leuven | Leave a comment

Psychological Interventions For Dementia: Putting the Person at the Centre of Care (BPS)

Posted on November 20, 2016 by Dementia and Elderly Care News

Summary The British Psychological Society’s Dementia Advisory Group has produced a report on the psychological aspects of dementia care; particularly covering the roles of psychologists in providing practical support. Recommendations are presented concerning: Prevention / risk-reduction. Assessment. Planning of care. … Continue reading →

Posted in Antipsychotics, Commissioning, Delirium, Depression, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Northern Ireland, Person-Centred Care, Personalisation, Quick Insights, Scotland, Standards, Statistics, UK, Universal Interest, Wales | Tagged Alternatives to Antipsychotic Medication, Alternatives to Antipsychotics, Assessment and Diagnosis, Behavioural Alternatives to Antipsychotic Drugs, Behavioural and Psychological Symptoms of Dementia (BPSD), BPSD: Behavioral and Psychological Symptoms of Dementia, British Psychological Society (BPS), British Psychological Society Dementia Advisory Group, British Psychological Society’s Dementia Advisory Group, Care Planning, Challenging Behaviour in Dementia, Dementia Advisory Group (British Psychological Society), Dementia as a Problematic Experience, Dementia Diagnosis, Dementia Research, Dementia Risk Prevention, Dementia Risk Reduction and Prevention, Dementia Training and Research, Elderly Mental Health, Families and Carers, Families and Carers as Partners in Dementia Care, Healthy Lifestyles, Involvement of Families and Carers, Join Dementia Research, Lifestyle Risk Factors, Management of Challenging Behaviour, Participation in Research, Prevention, Psychological Approaches in Managing Psychological and Behavioural Distress, Psychological Dimensions of Dementia, Psychological Interventions For Dementia, Psychological Problems of Older People, Psychological Symptoms of Dementia (BPSD), Public Involvement in Research, Risk Reduction (Formerly Termed Prevention by WDC), Treatment and Support (Psychological Interventions) | Leave a comment

Lost and All At Sea: Game-Players Feed Dementia Research? (BBC News / Neuroscience 2016 Conference / Alzheimer’s Research UK)

Posted on November 17, 2016 by Dementia and Elderly Care News

Summary Researchers at University College London have used a popular video game called Sea Hero Quest to investigate how players’ sense of direction and navigational ability typically decline over a lifetime. Analysis of the results could help dementia researchers develop … Continue reading →

Posted in Alzheimer’s Research UK, BBC News, Charitable Bodies, Diagnosis, For Researchers (mostly), In the News, International, Quick Insights, UK, Universal Interest | Tagged Alzheimer’s Research UK (ARUK), ARUK: Alzheimer’s Research UK, BBC Health News, Bournemouth University, Christoph Hölscher: ETH Zurich, Cross-Sector Collaboration, Decline in Navigational Ability, Dementia Research, Denmark, Deutsche Telekom’s Sea Hero Quest Project, Disorientation, Dr Hugo Spiers: UCL Institute of Behavioural Neuroscience, Dr. Axel Wehmeier: Managing Director of Telekom Healthcare Solutions, Ed Manley: University College London, ETH Zurich, Finland, Glitchers, Global Benchmark of Human Spatial Navigation, Hilary Evans: Chief Executive of Alzheimer’s Research UK, Human Spatial Navigation, Jan Weiner: Bournemouth University, Loss of Sense of Direction, McGill University, Michael Hornberger: University of East Anglia, Multisectoral Collaboration, Navigational Ability, Neuroscience 2016 Conference, Nordic Countries (Superior Navigational Skills), Northumbria University, Norway, Ricardo Silva: University College London, Ruth Dalton: Northumbria University, Saber Sami: University of Cambridge, Sea Hero Quest (Game), Sense of Direction, Spatial Disorientation, Spatial Navigation Tests of Disorientation, Spiers Lab, Sweden, UCL Spatial Cognition Group, University College London, University College London (UCL), University of Cambridge, University of East Anglia, Veronique Bohbot: McGill University | Leave a comment

MRC DRI Momentum Awards £4.3 Million For UK Dementia Research (MRC)

Posted on October 25, 2016 by Dementia and Elderly Care News

Summary Momentum Awards, which support the UK Dementia Research Institute (DRI). Today’s announcement involves six universities being awarded £4.3 million from the MRC to help develop UK-based dementia research. Judging from the press release, there appears to be a serious … Continue reading →

Posted in Commissioning, For Researchers (mostly), In the News, National, Quick Insights, UK, Universal Interest | Tagged Autism, Autism Spectrum Disorder (ASD), Biomarkers, Biomarkers Research Programmes, Bioscience Careers, Cardiff University, Computational Approaches to Discovery of Behavioural Signatures, Cross-Disciplinary Interfaces Exploring Emerging Scientific Opportunities, Dementia Research, Dementia Research Careers, Dementia Research Institute (DRI), Dr Kathryn Adcock: Head of Neurosciences and Mental Health at MRC, Epilepsy, Frontiers in Neuroscience, High Risk-High Payoff Research Projects (sic) [For Whom?], Human Brain Cell Types, Immune Pathways and Stem Cell (iPSC) Models of Neurodegenerative Disease, Institute of Psychiatry Psychology and Neuroscience (IoPPN), Kings College London, Maurice Wohl Clinical Neuroscience Institute, Momentum Awards, MRC Centre for Neurodevelopmental Disorders (King’s College London), MRC DRI Momentum Awards, MRC: Medical Research Council, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurodegenerative Research, Neurodevelopmental Disorders: Abnormal Brain Development, Neuroinflammation, Neuroinflammation Research Cluster, Neuroscience, Neurovascular Dysfunction, Potential Drug Targets, Professor Oscar Marín: Director of Department of Developmental Neurobiology at Institute of Psychiatry Psychology and Neuroscience (IoPPN), Proteostasis, Proteostasis Dysfunction, Pump-Priming (Dementia Research), Recruitment of Research Leaders / Rising Stars, Research and Development, Research and Innovation, Research Careers, Research Commitment, Research Culture, Research Funding, Schizophrenia, Sensor Platform for Healthcare in a Residential Environment (SPHERE), Signalling Pathways, Treatment and Prevention Targets, UK Dementia Research Institute, University of Bristol, University of Edinburgh, University of Manchester, University of Oxford | Leave a comment

Tag Archives: Dementia Research

Earlier Diagnosis Research: the Deep and Frequent Phenotyping Study (BBC News / GtR)

David Cameron on Need for Increasing Dementia Research Funding (BBC News)

Future Director of the UK Dementia Research Institute (MRC / Guardian / JAMA Neurology)

Lost and All At Sea: Game-Players Feed Dementia Research? (BBC News / Neuroscience 2016 Conference / Alzheimer’s Research UK)

MRC DRI Momentum Awards £4.3 Million For UK Dementia Research (MRC)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites